Detalhe da pesquisa
1.
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.
Blood
; 137(7): 896-907, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32976576
2.
Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.
Rheumatology (Oxford)
; 61(8): 3317-3328, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875023
3.
Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosis.
Am J Hematol
; 95(4): 387-394, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31903638
4.
An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.
Blood
; 130(19): 2131-2145, 2017 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28851699
5.
T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.
Blood
; 128(13): 1688-700, 2016 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27412889
6.
Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.
J Immunol
; 197(9): 3490-3503, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27694491
7.
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 23(2): 211-234, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27713092
8.
Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide.
J Neurooncol
; 135(2): 343-351, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28756593
9.
Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo.
Stem Cells
; 33(4): 1200-12, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25532725
10.
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.
Biol Blood Marrow Transplant
; 21(5): 780-92, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25644957
11.
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.
Blood
; 121(15): 2864-74, 2013 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23426943
12.
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.
Blood
; 122(25): 4129-39, 2013 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24055823
13.
Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation.
Blood
; 119(12): 2956-9, 2012 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22289893
14.
High-dose Alemtuzumab-Cyclosporine vs Tacrolimus-Methotrexate-Sirolimus for Chronic Graft-versus-Host Disease Prevention.
Blood Adv
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669315
15.
Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.
Blood Adv
; 8(3): 667-680, 2024 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113462
16.
Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
; 19(10): 1509-13, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23948062
17.
Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation.
Blood
; 117(19): 5250-6, 2011 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21421838
18.
Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.
JCI Insight
; 8(11)2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129971
19.
Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease.
iScience
; 25(1): 103592, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35005541
20.
Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.
Transplant Cell Ther
; 28(5): 264.e1-264.e9, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35114411